349
Views
22
CrossRef citations to date
0
Altmetric
Amenorrhea

Serum anti-Müllerian hormone, inhibin B, and total inhibin levels in women with hypothalamic amenorrhea and anorexia nervosa

, , , , , & show all
Pages 34-38 | Received 03 Mar 2011, Accepted 30 Mar 2011, Published online: 01 Jun 2011

References

  • Josso N, di Clemente N, Gouédard L. Anti-Müllerian hormone and its receptors. Mol Cell Endocrinol 2001;179:25–32.
  • La Marca A, Malmusi S, Giulini S, Tamaro LF, Orvieto R, Levratti P, et al. Anti-Mullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation. Hum Reprod 2004;19:2738–2741.
  • Groome NP, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Mether JP, et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 1996;81:1401–1405.
  • Lockwood GM, Muttukrishna S, Ledger WL. Inhibins and activins in human ovulation, conception and pregnancy. Hum Reprod Update 1998;4:284–295.
  • Tsigkou A, Marrelli D, Reis FM, Luisi S, Silva-Filho AL, Roviello F, et al. Total inhibin is a potential serum marker for epithelial ovarian cancer. J Clin Endocrinol Metab 2007;92:2526–2531.
  • Foster C, Philipps D, Wyman T, Evans L, Groome N, Padmanabhan V. Changes in serum inhibin, activin, and follistatin concentrations during pruberty in girls. Hum Reprod 2000;15:1052–1057.
  • Sowers MR, Eyvazzadeh AD, McConnel D, Yosef M, Jannausch, Harlow S, et al. Anti-Mulleran hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab 2008;81:2742–2745.
  • Practice Committee of American Society for Reproductive Medicine. Current evaluation of amenorrhea. Fertil Steril 2008;90:S219–S225.
  • Marcus MD, Loucks TL, Berga SL. Psychological correlates of functional hypothalamic amenorrhea. Fertil Steril 2001;76:310–316.
  • Perkins RB, Hall JE, Martin KA. Neuroendocrine abnormalities in hypothalamic amenorrhea: spectrum, stability, and response to neurotransmitter modulation. J Clin Endocrinol Metab 1999;84:1905–1911.
  • Genazzani AD, Ricchieri F, Lanzoni C, Strucchi C, Jasonni VM. Diagnostic and therapeutic approach to hypothalamic amenorrhea. Ann NY Acad Sci 2006;1092:103–113.
  • Resch M, Szendei G, Haasz P. Eating disorders from a gynecologic and endocrinologic view: hormonal changes. Fertil Steril 2004;81:1151–1153.
  • Hoek HW. Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. Curr Opin Psychiatry 2006;19:389–394.
  • American Psychiatric Association Press. Diagnostic and statistical manual of mental disorders. DSM-IV. 4th ed. Washington, D.C: American Psychiatric Association Press; 1994.
  • Riggs RM, Duran EH, Baker MW, Kimble TD, Hobeika E, Yin L, et al. Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age. Am J Obstet Gynecol 2008;199:202.e1–202.e8.
  • Tsepelidis S, Devreker F, Demeestere I, Flahaut A, Gervy Ch, Englert Y. Stable serum levels of anti-Müllerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women. Hum Reprod 2007;22:1837–1840.
  • Maheshwari A, Fowler P, Bhattacharya S. Assessment of ovarian reserve – should we perform tests of ovarian reserve routinely? Hum Reprod 2006;21:2729–2735.
  • Luisi S, Florio P, Reis FM, Petraglia F. Inhibins in female and male reproductive physiology: role in gametogenesis, conception, implantation and early pregnancy. Hum Reprod Update 2005;11:123–135.
  • La Marca A, Pati M, Orvieto R, Stabile G, Carducci Artenisio A, et al. Serum anti-Müllerian hormone levels in women with secondary amenorrhea. Fertil Steril 2006;85:1547–1549.
  • Van Disseldorp J, Faddy MJ, Themmen AP, de Jong FH, Peeters PH, van der Schouw YT. Broekmans relationship of serum antimulleran hormone concentration to age at menopause. J Clin Endocrinol Metab FJ 2008;93:2129–2134.
  • Van Rooij IA, Tonkelaar I, Broekmans FJ, Looman CW, Scheffer GJ, de Jong FH, et al. Anti-Mullerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 2004;11:601–606.
  • Van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, de Jong FH, et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril 2005;83:979–987.
  • Burger HG, Hale GE, Robertson DM, Dennerstein L. A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project. Hum Reprod Update 2007;13:559–565.
  • Klein NA, Houmard BS, Hansen KR, Woodruff TK, Sluss PM, Bremner WJ, et al. Age related analysis of inhibin A, inhibin B, and activin a relative to the intercycle monotropic follicle-stimulating hormone rise in normal ovulatory women. J Clin Endocrinol Metab 2004;89:1401–1405.
  • Reame NE, Wyman TL, Phillips DJ, de Kretser DM, Padmanabhan V. Net increase in stimulatory input resulting from a decrease in inhibin B and an increase in activin A may contribute in part to the rise in follicular phase follicle-stimulating hormone of aging cycling women. J Clin Endocrinol Metab 1998;83:3302–3307.
  • Petraglia F, Hartmann B, Luisi S, Florio P, Kirchengast S, Santuz M, et al. Low levels of serum inhibin A and inhibin B in women with hypergonadotropic amenorrhea and evidence of high levels of activin A in women with hypothalamic amenorrhea. Fertil Steril 1998;70:907–912.
  • Crofton PM, Evans AEM, Groome NP, Taylor MRH, Holland CV, Kelnar CJK. Dimeric inhibins in girls from birth to adulthood: relationship with age, prepubertal stage, FSH and estradiol. Clin Endocrinol 2002;56:223–230
  • La Marca A, Volpe A. Anti-Mullerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? Clin Endocrinol 2006;64:603–610.
  • Knauff EA, Eijkemans MJ, Lambalk CB, Ten Kate-Booij MJ, Hoek A, Beerendonk CC, et al. Anti mullerian hormone, inhibin B, and antral follicle count in young women with varying degrees of hypergonadotropic ovarian failure. J Clin Endocrinol Metab 2009;94:786–792.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.